Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents

Published:2013-02-13 Issue:2 Volume:29 Page:215-222
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Sadek Maiada M.¹,Serrya Rabah A.²,Kafafy Abdel-Hamid N.³,Ahmed Marawan⁴,Wang Feng⁴,Abouzid Khaled A. M.²

Affiliation:

1. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, MSA University 6th October, CairoEgypt

2. Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University CairoEgypt

3. Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Assiut University Abbassia, CairoEgypt

4. Chemistry Laboratory, Faculty of Life and Social Sciences, Swinburne University of Technology Melbourne, VictoriaAustralia

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/14756366.2013.765417

Reference25 articles.

1. Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer

2. Intracellular signaling pathways of ErbB2/HER-2 and family members

3. Tyrphostins and Other Tyrosine Kinase Inhibitors

4. Gefitinib (ZD1839, IressaR) in non-small-cell lung cancer: a review of clinical trials from a daily practice perspective

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer;European Journal of Medicinal Chemistry Reports;2024-08

2. Advances in Small-Molecule Dual Inhibitors Targeting EGFR and HER2 Receptors as Anti-Cancer Agents;Current Medicinal Chemistry;2024-06-10

3. Privileged Scaffolds in Drug Discovery against Human Epidermal Growth Factor Receptor 2 for Cancer Treatment;Current Pharmaceutical Design;2023-12

4. Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review;International Journal of Biological Macromolecules;2023-12

5. Novel 7-Deazapurine Incorporating Isatin Hybrid Compounds as Protein Kinase Inhibitors: Design, Synthesis, In Silico Studies, and Antiproliferative Evaluation;Molecules;2023-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3